11/04/2015 - 3:29pm

The National Association of Chain Drug Stores Foundation announced that it had promoted NACDS pharmacy care and patient advocacy staffer as its new research programs director.

11/04/2015 - 3:14pm

The APhA on Oct. 28, along with the National Association of Chain Drug Sotres, the American Society of Health-System Pharmacists, the National Community Pharmacists Association and Walgreens, held its third annual Capitol Hill Health Fair, providing flu vaccinations and health screenings. The event was also partly sponsored by U.S. Rep. Buddy Carter, R-Ga., who is a registered pharamacist (pictured). (APhA)

11/04/2015 - 2:21pm

For the full-year 2015, Diplomat Pharmacy now expects revenue between $3.25 and $3.4 billion, up from a previous range of $3.2 to $3.4 billion.

11/04/2015 - 1:19pm

The New York Times reported Tuesday that embattled drug maker Turing Pharmaceuticals, which made headlines when it acquired Daraprim and raised the price by more than 5,000% overnight, had announced a planned drop in price by the end of 2015. The Times pointed out that the 10% decrease. “Since acquiring Daraprim three months ago, our top priority has been to ensure that patients who need Daraprim have ready, affordable access to it,” Turing said in a letter. (New York Times)

11/04/2015 - 11:56am

Drug Store News spoke to Zipdrug’s founder and CEO Stu Libby about the start-up's first few months in business and how it’s looking to change the way patients get their medication. 

11/03/2015 - 4:21pm

With the completion of this step all Mylan needs is word from Perrigo’s shareholders on whether or not they will accept the company’s $27 billion acquisition offer, which was tendered on Sept. 14. 

11/03/2015 - 3:30pm
Using VoicePort’s PharmaPhonetics system, the partnership is aimed at finding immunization gaps in patient records for pharmacists.
11/03/2015 - 2:57pm

Thinfilm’s NFC OpenSense tags are thin labels that can tell whether the injector has been used or not, and can send information about the injector’s state to a smartphone

11/03/2015 - 2:31pm
The Regulartory Affairs Professionals Society is reporting that as part of the recently passed budget deal that the president signed Monday, generics companies whose prices rise beyond the Average Manufacturer Price that’s adjusted for inflation will have to pay higher rebates. “The amount of the rebate specified in this paragraph for a rebate period, with respect to each dosage form and strength of a covered outpatient drug other than a single source drug or an innovator multiple source drug of a manufacturer, shall be increased in the manner that the rebate for a dosage form and strength of a single source drug or an innovator multiple source drug is increased,” the act says. (RAPS)